Citius Pharmaceuticals, Inc.
Pharmaceutical company · Cranford, New Jersey, United States · Nasdaq: CTXR
Citius Pharmaceuticals, Inc. is a pharmaceutical company headquartered in Cranford, New Jersey, United States. Its shares trade on Nasdaq under the ticker CTXR. It has reported private securities offerings to the US SEC, most recently $20 million sold in a notice filed in 2021.
Citius Pharmaceuticals at a glance
What does Citius Pharmaceuticals do?
Private fundraising reported to the SEC
7 Form D notices; the most recent reported $20 million sold (2021).
Frequently asked questions about Citius Pharmaceuticals
Where is Citius Pharmaceuticals headquartered?
Citius Pharmaceuticals, Inc. is headquartered in Cranford, New Jersey, United States.
What does Citius Pharmaceuticals do?
Citius Pharmaceuticals, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.
Is Citius Pharmaceuticals a public company?
Yes. Citius Pharmaceuticals, Inc. trades on Nasdaq under the ticker CTXR.
Similar companies
- AbbVie Inc.North Chicago, Illinois, United States
- Savara IncAustin, Texas, United States
- Crinetics Pharmaceuticals, Inc.San Diego, California, United States
- Cartesian Therapeutics, Inc.Frederick, Maryland, United States
- Karyopharm Therapeutics Inc.Newton, Massachusetts, United States
- Dare Bioscience, Inc.San Diego, California, United States
- Cellectar Biosciences, Inc.Florham Park, New Jersey, United States
- Marker Therapeutics, Inc.Houston, Texas, United States
Need a CRO or CDMO for your next study?
Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.
Compare quotesSources
Location data: GeoNames (geonames.org), CC BY 4.0.
Last updated 2026-09-23.